Treatment of deep mycoses with liposomal amphotericin B
- 1 June 1994
- journal article
- other
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 13 (6) , 504-507
- https://doi.org/10.1007/bf01974643
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990The Journal of Infectious Diseases, 1993
- Early Pharmacokinetic and Clinical Results from a Noncomparative Multicentre Trial of Amphotericin B Encapsulated in a Small Unilamellar Liposome (AmBisome®)Clinical Drug Investigation, 1992
- Successful Treatment of Fungal Infections in Neutropenic Patients with Liposomal Amphotericin (AmBisome)—A Report on 40 Cases from a Single CentreLeukemia & Lymphoma, 1992
- Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Rhinocerebral mucormycosis: Use of liposomal amphotericin BThe Journal of Laryngology & Otology, 1991
- Amphotericin B: delivery systemsAntimicrobial Agents and Chemotherapy, 1990
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- ACUTE RENAL TOXICITY WITH COMBINED USE OF AMPHOTERICIN B AND CYCLOSPORINE AFTER MARROW TRANSPLANTATIONTransplantation, 1983